NLRP3 and COVID-19: It has been reported that inflammasome activation is triggered by SARS-CoV-2 components [40,41], that its higher activation is possibly involved in COVID-19 severity [42], and that the specific inhibition of the NLRP3 inflammasome was able to decrease the intensity of a COVID-19-like pathology in mice [43].